Solid Biosciences LLC
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.5 | 4.8 | 3.9 | 2.5 | 14.8 | 11.1 | 4.7 | 4.7 | 2.7 | 6.4 | 12.6 | 6.2 | 37.4 | 107.1 | 49.3 | 61.3 | 68.6 | 78.6 | 147.7 | 187.4 | – | – | – | |
| – | – | – | – | – | – | 1.2 | 7.6 | 11.2 | 7.4 | 3.2 | 2.6 | 4.1 | 2.7 | 2.0 | 3.4 | 4.3 | 4.1 | 1.9 | 1.7 | 1.2 | 1.0 | 0.7 | 0.4 | 0.4 | 0.2 | 0.5 | 0.6 | 0.3 | 1.4 | 2.4 | 1.2 | 1.7 | 1.6 | 0.8 | 1.8 | 2.7 | 2.9 | 2.1 | 3.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.9 | 2.2 | 2.1 | 1.5 | 6.2 | 0.5 | 1.1 | 0.5 | -6.8 | -4.9 | 1.6 | 0.4 | 22.2 | 82.8 | 29.5 | 48.2 | 43.9 | 12.1 | 104.1 | 168.5 | – | – | – | |
| – | – | – | – | – | – | -24.2% | -5.1% | -4.3% | -8.4% | -27.4% | -47.3% | -21.9% | -44.9% | -86.0% | -60.8% | -83.5% | -10.7% | -10.0% | -12.8% | -20.9% | -39.1% | -62.9% | -120.9% | -164.2% | -233.1% | -111.0% | -110.6% | -219.6% | -54.1% | -18.2% | -37.0% | -31.6% | -47.0% | -43.7% | -26.7% | -22.7% | -29.7% | -21.9% | -13.1% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 22.6% | 38.0% | 54.8% | 100.0% | 100.0% | 100.0% | 96.1% | 94.0% | 85.6% | 65.9% | 64.1% | -62.4% | -46.6% | -57.8% | -53.9% | -78.6% | -81.1% | -54.0% | -53.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -89.9% | -77.2% | -74.2% | -68.9% | -530.5% | -661.3% | -591.4% | -804.9% | -657.6% | -793.0% | -1,415.5% | -1,440.0% | -2,201.3% | -2,092.1% | -2,112.1% | -2,366.9% | -4,152.6% | -4,574.8% | -5,019.9% | -5,432.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -89.8% | -77.2% | -74.3% | -68.9% | -530.0% | -660.2% | -588.5% | -795.2% | -531.1% | -636.1% | -1,115.1% | -1,122.2% | -2,027.3% | -1,905.6% | -1,914.9% | -2,162.9% | -3,991.6% | -4,471.1% | -4,932.3% | -5,350.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -58.5% | -48.1% | -50.6% | -51.7% | -580.4% | -696.3% | -572.1% | -775.2% | -623.9% | -716.0% | -1,397.4% | -1,360.5% | -2,020.6% | -1,953.9% | -1,821.9% | -1,936.9% | -3,222.3% | -3,434.7% | -3,948.0% | -4,262.8% | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -192.4% | – | -30.8% | -38.1% | -46.4% | -59.8% | -89.3% | -126.9% | -98.9% | -146.4% | -202.5% | -262.3% | -444.4% | -66.8% | -31.0% | -32.9% | -33.6% | -34.7% | -43.5% | -53.6% | -62.4% | -40.6% | -49.4% | -55.1% | -62.9% | -75.9% | -42.8% | -46.9% | -61.3% | -90.9% | -47.4% | -59.7% | -76.7% | -96.8% | -51.3% | -55.4% | |
| – | – | – | – | -128.0% | -68.4% | -29.2% | -36.1% | -43.0% | -53.6% | -73.6% | -100.8% | -81.9% | -113.3% | -154.6% | -184.3% | -243.8% | -51.6% | -27.5% | -29.4% | -30.1% | -31.1% | -38.8% | -41.7% | -48.5% | -33.0% | -39.5% | -44.1% | -49.2% | -58.2% | -36.3% | -39.3% | -48.4% | -66.1% | -40.6% | -50.0% | -61.0% | -75.0% | -45.3% | -49.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | -165 | -146 | -129 | -86 | -47 | -50 | -93 | -74 | -51 | -38 | -23 | -153 | -266 | -199 | -108 | -118 | -128 | -54 | -47 | -153 | -162 | -89 | -47 | -72 | -115 | -94 | -62 | -77 | -208 | -136 | -59 | -58 | -296 | -157 | |
| – | -207.6% | – | – | 66.6% | -77.8% | 94.6% | 94.6% | 92.5% | 89.7% | 82.4% | 79.4% | 82.9% | 77.4% | 76.3% | 70.2% | 54.9% | 77.2% | 88.7% | 89.5% | 89.7% | 89.6% | 89.4% | 77.8% | 77.7% | 81.3% | 80.1% | 80.0% | 78.1% | 76.7% | 84.7% | 83.7% | 78.8% | 72.7% | 85.6% | 83.8% | 79.6% | 77.4% | 88.5% | 88.9% | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -35.40 | -40.65 | -28.20 | -26.93 | -29.25 | -32.27 | -38.18 | -41.78 | -37.02 | -36.59 | -35.69 | -33.26 | -30.68 | -18.76 | -13.19 | -10.45 | -10.01 | -9.64 | -10.74 | -11.56 | -11.87 | -10.72 | -4.64 | -4.59 | -4.53 | -3.31 | -2.37 | -2.22 | -2.47 | -2.33 | -2.11 | -1.64 | -1.77 | -1.84 | -1.75 | -1.44 | |
| – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.89 | 17.08 | 14.06 | 14.54 | 1.82 | 1.63 | 1.97 | 1.49 | 2.02 | 0.73 | 0.41 | 0.40 | 0.16 | 0.12 | 0.12 | 0.11 | 0.06 | 0.05 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | |
| – | -48.14 | 26.34 | – | 18.40 | -46.22 | 91.44 | 70.65 | 62.99 | 54.00 | 42.76 | 32.93 | 37.45 | 24.98 | 17.62 | 12.68 | 6.90 | 28.06 | 42.51 | 31.78 | 29.85 | 27.81 | 24.71 | 21.56 | 19.02 | 26.38 | 9.39 | 8.33 | 7.20 | 4.36 | 5.52 | 4.72 | 4.03 | 2.56 | 4.44 | 2.74 | 2.31 | 1.90 | 3.41 | 2.60 | |
| – | – | – | – | -28.80 | -35.49 | -27.20 | -27.48 | -30.15 | -33.64 | -37.83 | -41.14 | -33.83 | -30.31 | -30.95 | -26.43 | -25.04 | -12.22 | -8.22 | -7.11 | -7.52 | -10.56 | -11.33 | -11.24 | -11.57 | -12.59 | -5.22 | -5.75 | -5.49 | -3.30 | -2.43 | -2.11 | -2.21 | -1.88 | -1.62 | -1.31 | -1.41 | -1.66 | -1.57 | -1.31 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.